Land O’Lakes: Analytical Considerations for Antibody Drug Conjugates


Biopharmaceuticals side view, illustrating the development of drugs using genetic engineering - drug development, cybernetic tone, Monochromatic Color Scheme

http://player.vimeo.com/video/72477211In collaboration with the University of Wisconsin, Bioanalysis Zone is
pleased to feature a presentation by leading expert Surinder Kaur on bioanalysis of antibody-drug conjugates from the 14th Land O’Lakes Bioanalytical Conference.

In this exclusive recording of Surinder’s presentation, you will learn more about the growing area of antibody-drug conjugates. Why do antibody-drug conjugates require complex bioanalytical strategies? How can you integrate ligand binding, LC-MS and hybrid assay strategies? Find out in this fantastic talk.

More presentations from the 14th Land O’Lakes Bioanalytical Conference:

Whole Blood Sample Handling and Collection Stability: A Case Study (Joy Hoesing)

Outsourcing from a CRO Perspective (Brian O’Dwyer)

Global Regulatory Issues (Peter van Amsterdam)

You can view the program for next year’s conference on the event website.